A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/74 (2006.01)
Patent
CA 2522043
Methods and compositions are provided for preventing, reducing and reversing ischemic neuronal damage related to congenital and acquired ophthalmologic conditions such as macular degeneration, retinitis pigmentosa, optic neuritis, neuroretinitis, Lebers congenital amaurosis, Stargardts disease, Parkinson's disease, diabetic retinopathy, idiopathic senile vision loss, uveitis, edema and ocular surgery. An amount of an acetylcholine esterase inhibitor containing composition is administered to the eye of a mammal, either topically or via a controlled-release drug delivery system.
L'invention concerne des procédés et des compositions pour prévenir, réduire et inverser les lésions neuronales ischémiques liées à des états ophtalmologiques congénitaux ou acquis tels quel la dégénérescence maculaire, retinitis pigmentosa, la névrite optique, la neurorétinite, l'amaurose congénitale de Lebers, la maladie de Stargardts, la maladie de Parkinson, la rétinopathie diabétique, la perte de vision sénile idiopathique, l'uvéite, l'oedème et la chirurgie oculaire. Une quantité nécessaire d'une composition contenant un inhibiteur d'estérase d'acétylcholine est appliquée à l'oeil d'un mammifère, de façon topique ou au moyen d'un système d'administration de médicaments à libération contrôlée.
Nolan Gerard M.
Borden Ladner Gervais Llp
Nolan Gerard M.
LandOfFree
Method and composition for preventing, reducing and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for preventing, reducing and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for preventing, reducing and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1643921